-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CIOLlSigVEobHoVXgXpGLwPxGCnEJMouqGUC3s0aXbjJ7SIS4IUqESaJAdI9Psmr vNq2R285TR61IRVgqN+6ag== 0001140361-07-012727.txt : 20070620 0001140361-07-012727.hdr.sgml : 20070620 20070620194947 ACCESSION NUMBER: 0001140361-07-012727 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070620 FILED AS OF DATE: 20070620 DATE AS OF CHANGE: 20070620 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Iwanicki David CENTRAL INDEX KEY: 0001322481 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19756 FILM NUMBER: 07932400 BUSINESS ADDRESS: BUSINESS PHONE: 510-574-1400 MAIL ADDRESS: STREET 1: 34801 CAMPUS DRIVE CITY: FREMONT STATE: CA ZIP: 94555 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PDL BIOPHARMA, INC. CENTRAL INDEX KEY: 0000882104 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943023969 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 34801 CAMPUS DR CITY: FREMONT STATE: CA ZIP: 94555 BUSINESS PHONE: 5105741400 MAIL ADDRESS: STREET 1: 34801 CAMPUS DR CITY: FREMONT STATE: CA ZIP: 94555 FORMER COMPANY: FORMER CONFORMED NAME: PROTEIN DESIGN LABS INC/DE DATE OF NAME CHANGE: 19930328 4 1 doc1.xml FORM 4 X0202 4 2007-06-20 0 0000882104 PDL BIOPHARMA, INC. PDLI 0001322481 Iwanicki David C/O PDL BIOPHARMA, INC. 34801 CAMPUS DRIVE FREMONT CA 94555 0 1 0 0 VP, Sales & Sales Operations Common Stock 2007-06-20 4 M 0 645 17.13 A 645 D Common Stock 2007-06-20 4 S 0 60 24.35 D 585 D Common Stock 2007-06-20 4 S 0 65 24.30 D 520 D Common Stock 2007-06-20 4 S 0 65 24.32 D 455 D Common Stock 2007-06-20 4 S 0 65 24.33 D 390 D Common Stock 2007-06-20 4 S 0 65 24.36 D 325 D Common Stock 2007-06-20 4 S 0 65 24.43 D 260 D Common Stock 2007-06-20 4 S 0 65 24.48 D 195 D Common Stock 2007-06-20 4 S 0 65 24.50 D 130 D Common Stock 2007-06-20 4 S 0 65 24.53 D 65 D Common Stock 2007-06-20 4 S 0 65 24.55 D 0 D Employee Stock Option (Right to Buy) 17.13 2007-06-20 4 M 0 645 0 D 2013-07-20 Common Stock 645 23905 D Sale was made pursuant to a 10b5-1 plan established by the reporting person. Option vests with respect to approximately 645 shares per month and 9 shares remained exercisable immediately after this transaction. Only vested options are exercisable /s/ Francis Sarena by Francis Sarena, Attorney-in-Fact for David Iwanicki 2007-06-20 -----END PRIVACY-ENHANCED MESSAGE-----